CD-Chex Plus BC is a positive procedural control for monitoring immunophenotyping by flow cytometry on Beckman Coulter flow cytometry instruments. It provides 30 assayed CD parameters on a single control, including T-lymphocytes, B-lymphocytes, granulocytes, monocytes, and NK cells. It is available in two clinically relevant levels of CD4+ cells and is assayed for a normal level of CD34+ cells. Designed to mimic a patient sample, CD-Chex Plus BC is manufactured from normal human peripheral blood leukocytes and erythrocytes. The whole blood control offers 30-day open-vial stability. CD-Chex Plus BC features plastic vials with pierceable caps for use with automated flow cytometry sample preparation instruments, reducing errors and improving laboratory workflow.
Streck斯特里克在70年代早期开发了细胞稳定的核心技术,当时血细胞仍在用显微镜进行人工计数。通过分离和稳定血小板,我们的科学家能够促进自动计数,并开发出校准血小板计数设备的精确系统。
如今,Streck拥有20多种产品的40多项专利,并为一些行业领先的仪器制造商(如雅培、西门子和Sysmex等)制造测试和试剂材料。
Streck位于美国的中心地带,位于内布拉斯加州拉维斯塔市,占地20万平方英尺。在这里,我们的产品被制造并交付给世界65个国家的13000多个实验室。